Through improvements in radiopharmaceuticals and instrumentation, nuclear medicine continues to develop and refine in-vivo approaches for diagnosis (including staging and prognosis) and treatment of disease.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Frederick A Khafagi
- S Patrick Butler
- 1 Department of Nuclear Medicine and Cardiology, St Andrew's War Memorial Hospital, Brisbane, QLD.
- 2 Department of Nuclear Medicine, St George's Hospital, Sydney, NSW.
Correspondence: fkhafagi@bigpond.com
Responses are now closed for this article.